Bharat Biotech Confirms Deal With Brazil To Supply 20 Million Doses Of COVAXIN®

Bharat Biotech International Limited today confirmed that the company has signed an agreement with Brazil for supply of 20 million doses of COVAXIN®.

The company is delighted to partner with Brazil in its battle against Covid-19 and aid its immunization program against the virus. It has signed an agreement for delivery of COVAXIN® during Q2 and Q3 2021.

There is a strong interest in COVAXIN® from many countries around the world, and the company is fully committed to ensuring supplies promptly and efficiently.